Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causing the coronavirus
disease 2019 (COVID-19), has led to a global pandemic. However, the majority of currently …

Background Many studies report the seroprevalence of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) antibodies. We aimed to synthesize seroprevalence data to …

Objectives COVID-19 has been arguably the most important public health concern
worldwide in 2020, and efforts are now escalating to suppress or eliminate its spread. In this …

Background Thousands of medical staff had been infected with SARS-CoV-2 virus with
hundreds of deaths reported. Such loss could be prevented if there is a serologic assay for …

It is of paramount importance to evaluate the prevalence of both asymptomatic and
symptomatic cases of SARS-CoV-2 infection and their differing antibody response profiles …

Background The coronavirus disease 2019 (COVID-19), caused by infection with the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been rapidly spreading …

In order to fight the SARS-CoV-2 pandemic infection, there is a growing need and demand
for diagnostic tools that are complementary and different from the RT-PCR currently in use …

Background The prevalence of SARS-CoV-2 infection among health care workers (HCWs)
provides information about the spread of COVID-19 within health care facilities, and the risk …

Background Timely diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) infection is a prerequisite for treatment and prevention. The serology characteristics …

Estimated Community Seroprevalence of SARS-CoV-2 Antibodies — Two Georgia Counties,
April 28–May 3, 2020 | MMWR Skip directly to site content Skip directly to page options Skip …